Skip to Content

Clinical Trials
Patient Portal

Loading component...

Loading component...

EAP for AGEN2034 either monotherapy or as used in combo with zalifrelimab

Phase II Clinical Trial

Expanded Access for Cancer Treatment with Balstilimab (AGEN2034) either as Monotherapy or as used in Combination with Zalifrelimab (AGEN1884)

Trial Number: 05572970

Trial Status: OPEN

Learn more about this clinical trial.

About Us
Specialities & Services
Request Appointment
Careers
Contact Us
Media Center
Cancer Support Services
Careopolis

Find a Provider
Find a Location
Clinical Trials
Patient Portal
Patient Forms
Patient Resources
Patient Rights & Privacy
Insurance Information

© 2026 Texas Oncology. All rights reserved.|Privacy Notice|Terms of Use